There are currently no specific drugs to treat COVID-19, the disease caused by the novel coronavirus.
. It also manufactures drugs for other respiratory diseases like the flu and chronic pulmonary infections, as well as HIV/As the drug has not been approved, it's unclear how much it will cost. In an earnings call with investors on Thursday, Gilead CEO Daniel O'Day said according to:"Under the emergency-use authorization [which could be issued by the FDA], one could charge for the product.
The study involved 1,063 people, and suggested those who took the drug were able to leave hospital 31 percent faster than those in the placebo group, at 11 versus 15 days. In addition, the mortality rate of the patients who took the drug was 8 percent percent compared with 11.6 percent for the others, but this finding was not considered statistically significant.
"We await with interest a more detailed report of the results of this study, as well as those from other ongoing trials of this drug in several other countries including the UK. If these findings are confirmed, they would represent a major advance in the fight against this life threatening infection."and 79 assigned a placebo, however, found no benefit compared with a placebo.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA allows emergency use of drug for coronavirus
Read more »
FDA Issues Emergency Approval For Coronavirus Treatment DrugBREAKING: The Food and Drug Administration has approved the experimental drug remdesivir for treating coronavirus patients.
Read more »
FDA Issues Emergency Approval For Coronavirus Treatment DrugBREAKING: The Food and Drug Administration has approved the experimental drug remdesivir for treating coronavirus patients.
Read more »
FDA Gives Remdesivir Emergency AuthorizationNEW: The FDA approved an emergency use authorization for the experimental antiviral drug remdesivir to treat COVID-19. What you need to know:
Read more »
FDA authorizes remdesivir for emergency use against coronavirus pandemicA government-sponsored study showed the drug shortens patients' recovery times by 31 percent or an average of about four days.
Read more »